Canada markets closed
  • S&P/TSX

    20,144.04
    -86.92 (-0.43%)
     
  • S&P 500

    4,221.86
    -1.84 (-0.04%)
     
  • DOW

    33,823.45
    -210.22 (-0.62%)
     
  • CAD/USD

    0.8100
    +0.0006 (+0.07%)
     
  • CRUDE OIL

    70.57
    -0.47 (-0.66%)
     
  • BTC-CAD

    46,299.05
    -1,906.63 (-3.96%)
     
  • CMC Crypto 200

    931.15
    -38.73 (-3.99%)
     
  • GOLD FUTURES

    1,784.40
    +9.60 (+0.54%)
     
  • RUSSELL 2000

    2,287.46
    -27.23 (-1.18%)
     
  • 10-Yr Bond

    1.5110
    -0.0580 (-3.70%)
     
  • NASDAQ futures

    14,202.00
    +36.50 (+0.26%)
     
  • VOLATILITY

    17.75
    -0.40 (-2.20%)
     
  • FTSE

    7,153.43
    -31.52 (-0.44%)
     
  • NIKKEI 225

    29,105.93
    +87.60 (+0.30%)
     
  • CAD/EUR

    0.6794
    0.0000 (0.00%)
     

Capricor: Q1 Earnings Snapshot

·1 min read

BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $5.2 million in its first quarter.

The Beverly Hills, California-based company said it had a loss of 23 cents per share.

The biotechnology company posted revenue of $40,800 in the period. Its adjusted revenue was $41,000.

In the final minutes of trading on Thursday, the company's shares hit $3.16. A year ago, they were trading at $6.66.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting